Quinapril Hydrochloride Tablet shortage
Current 16 presentations · 4 manufacturers · first FDA posting 2023-01-19 · last update 2026-10-13
Manufacturers: Aurobindo Pharma USA, Chartwell Molecular Holdings LLC, Lupin Pharmaceuticals, Inc., Solco Healthcare US, LLC
Stated reasons (per FDA): Discontinuation of the manufacture of the drug; Requirements related to complying with good manufacturing practices; Shortage of an active ingredient
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Quinapril Hydrochloride, Tablet, 5 mg (NDC 65862-617-90) | Aurobindo Pharma USA | Current Unavailable |
Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug | Posted 01/19/2023 Updated 10/02/2026 |
| Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) | Aurobindo Pharma USA | Current Unavailable |
Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug | Posted 01/19/2023 Updated 10/02/2026 |
| Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) | Aurobindo Pharma USA | Current Unavailable |
Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug | Posted 01/19/2023 Updated 10/02/2026 |
| Quinapril Hydrochloride, Tablet, 40 mg (NDC 65862-620-90) | Aurobindo Pharma USA | Current Unavailable |
Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug | Posted 01/19/2023 Updated 10/02/2026 |
| Quinapril Hydrochloride, Tablet, 5 mg (NDC 62135-484-60) | Chartwell Molecular Holdings LLC | Current Available |
— | Posted 01/19/2023 Updated 10/02/2026 | |
| Quinapril Hydrochloride, Tablet, 10 mg (NDC 62135-485-90) | Chartwell Molecular Holdings LLC | Current Available |
— | Posted 01/19/2023 Updated 10/02/2026 | |
| Quinapril Hydrochloride, Tablet, 20 mg (NDC 62135-486-90) | Chartwell Molecular Holdings LLC | Current Available |
— | Posted 01/19/2023 Updated 10/02/2026 | |
| Quinapril Hydrochloride, Tablet, 40 mg (NDC 62135-487-90) | Chartwell Molecular Holdings LLC | Current Available |
— | Posted 01/19/2023 Updated 10/02/2026 | |
| Quinapril Hydrochloride, Tablet, 40 mg (NDC 68180-554-09) | Lupin Pharmaceuticals, Inc. | Current Unavailable |
Requirements related to complying with good manufacturing practices | Estimated recovery: TBD | Posted 01/19/2023 Updated 10/13/2026 |
| Quinapril Hydrochloride, Tablet, 5 mg (NDC 68180-556-09) | Lupin Pharmaceuticals, Inc. | Current Unavailable |
Requirements related to complying with good manufacturing practices | Estimated recovery: TBD | Posted 01/19/2023 Updated 10/13/2026 |
| Quinapril Hydrochloride, Tablet, 10 mg (NDC 68180-557-09) | Lupin Pharmaceuticals, Inc. | Current Unavailable |
Requirements related to complying with good manufacturing practices | Estimated recovery: TBD | Posted 01/19/2023 Updated 10/13/2026 |
| Quinapril Hydrochloride, Tablet, 20 mg (NDC 68180-558-09) | Lupin Pharmaceuticals, Inc. | Current Unavailable |
Requirements related to complying with good manufacturing practices | Estimated recovery: TBD | Posted 01/19/2023 Updated 10/13/2026 |
| Quinapril Hydrochloride, Tablet, 5 mg (NDC 43547-410-09) | Solco Healthcare US, LLC | Current Unavailable |
Shortage of an active ingredient | Not available. Long-term backorder for all NDCs. No estimated release date at this time. | Posted 01/19/2023 Updated 06/29/2026 |
| Quinapril Hydrochloride, Tablet, 10 mg (NDC 43547-411-09) | Solco Healthcare US, LLC | Current Unavailable |
Shortage of an active ingredient | Not available. Long-term backorder for all NDCs. No estimated release date at this time. | Posted 01/19/2023 Updated 06/29/2026 |
| Quinapril Hydrochloride, Tablet, 20 mg (NDC 43547-412-09) | Solco Healthcare US, LLC | Current Unavailable |
Shortage of an active ingredient | Not available. Long-term backorder for all NDCs. No estimated release date at this time. | Posted 01/19/2023 Updated 06/29/2026 |
| Quinapril Hydrochloride, Tablet, 40 mg (NDC 43547-413-09) | Solco Healthcare US, LLC | Current Unavailable |
Shortage of an active ingredient | Not available. Long-term backorder for all NDCs. No estimated release date at this time. | Posted 01/19/2023 Updated 06/29/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)